Hybridization System Articles & Analysis

Terex Utilities has received approval from the Air Resources Board (ARB) for its Terex® HyPower™ Hybrid System, a plug-in Power Take-Off (PTO) system that uses stored energy from the system’s rechargeable batteries to power the non-propulsion functions of the vehicle. This approval enables the HyPower system, which can be used on any heavy-duty, ...

By Terex

The High Value Manufacturing (HVM) Catapult is the go-to place for manufacturing technologies in the UK, supporting organisations of all sizes in their success. MACH 2020 is pleased to announce that the HVM Catapult will be exhibiting at the UK’s national manufacturing showcase this April. Their Catapult Trail, consisting of four stands across the exhibition, will demonstrate how they can ...

By The Manufacturing Technologies Association (MTA)

Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, is pleased to announce and welcome Jodie Fam as Vice President and General Manager, International. Jodie will be responsible for the leadership and development of International Sales for Q’Apel. Jodie brings more than 20 ...

By Q`Apel Medical Inc.

Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, is pleased to announce and welcome Thomas Berryman as Chief Financial Officer. Tom has extensive experience in bringing venture funded medical technology companies from initial startup through product commercialization, revenue ...

By Q`Apel Medical Inc.

Pentair, Inc. (NYSE: PNR), a global leader in water treatment solutions, today unveiled its new Hybrid Deionization (Hybrid DI) system with Pentair's CrossCharge technology, the first electronic water purification system that is practical for residential applications. Hybrid DI systems using CrossCharge technology will be the first to offer consumers the benefits of a reverse osmosis (RO) ...

By Pentair, Inc.

Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today it has raised $22 Million in Series C funding. The round included River Cities Capital, Soleus Capital and incumbent investor, Research Corporation Technologies (RCT). Scott Huennekens, former Chairman, CEO and ...

By Q`Apel Medical Inc.

New 35,000 square foot Facility will support the company’s growth and OUS expansion Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today that it will relocate its existing headquarters into a new building at 4245 Technology Dr, Fremont, CA, 94538. The 35,000 ...

By Q`Apel Medical Inc.

Nationally there is a trend moving towards radial artery access versus femoral artery access for endovascular procedures and Q’Apel Medical is leading the way. Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today the launch of the Armadillo Radial Access ...

By Q`Apel Medical Inc.

Recent advances in the architecture and scale of AI are leading us from the era of narrowly focused AI (e.g. text auto-complete, immune epitope prediction in a protein sequence, antibody domain detection) to broader models with applications across domains from sales and marketing to medical diagnostics. In protein biochemistry these are the “AIFold” models such as AlphaFold2, ...

By Cyrus Biotechnology Inc.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced real-world data confirming that use of the t:slim X2™ insulin pump with Control-IQ® advanced hybrid closed-loop technology resulted in immediate and ongoing improvements in glycemic control, quality of life outcomes, and user-reported reduced burden of diabetes management.1 The ...

By Tandem Diabetes Care, Inc.

EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements. Us2.ai’s technology received FDA approval on July 27, 2021 Us2.ai’s software is being ...

By EchoNous, Inc.

CMR Surgical & Surgical Innovations develop new surgical hybrid port access system Surgical Innovations’ new YelloPort Elite™ 5mm, with reusable trocar and canula, reduces cost and waste generated when compared with traditional fully single use Port Access Systems Developed with CMR Surgical, the port access system is the latest addition to Surgical Innovation’s ...

By Surgical Innovations Limited

BioVentrix, Inc., developer of the first hybrid transcatheter device for left ventricular remodeling after a heart attack, today announced that the Company has resumed cases in the pivotal ALIVE Trial studying Less Invasive Ventricular Enhancement, or LIVE™ Therapy, using the Revivent TC™ Transcatheter Ventricular Enhancement System. The first patient procedures completed since ...

By BioVentrix, Inc.

Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted approval of the Thoraflex Hybrid Frozen Elephant Trunk (FET) device for commercial sale in the United States for the treatment of patients with complex aortic arch disease. Thoraflex Hybrid is the first of its kind device used in Frozen Elephant Trunk (FET) repair in the United States and was granted ...

By Terumo Aortic

BioVentrix, Inc., developer of the first hybrid transcatheter device for left ventricular remodeling after a heart attack, today announced that it has been named by FierceMedTech as one of the “Fierce 15” for 2019, designating it as one of the most promising private medtech companies in the industry. The company offers Less Invasive Ventricular Enhancement, or the LIVE™ ...

By BioVentrix, Inc.

US Medical Innovations, LLC (USMI) announced today that it is developing the first robotic delivery system used for cancer surgery. The new Canady Surgical System (CSS) is a space-efficient, cost-effective, stand-alone solution for Robotic Assisted Surgery during open, laparoscopic/mini-invasive, endoscopic, thoracoscopic and trans-oral surgical procedures. Features of the new Canady Surgical ...

By US Medical Innovations, LLC

With the boom of nanotechnology, a growing number of nanomaterials have been applied to the pharmaceutical industry. For instance, nanoparticle-based drug delivery has become research of interest. More recently, CD Formulation, a trust worthy CRO partner for pharmaceutical companies worldwide, announced its commitment to developing suitable drug carriers by incorporating the power of ...

By CD Formulation

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced three abstracts, including two oral presentations and one poster, detailing data on type 1 diabetes (T1D) and its Phase 1/2 trial of VX-880, a stem cell-derived, fully differentiated pancreatic islet cell replacement therapy, have been accepted for presentation during the American Diabetes Association 82nd Annual Scientific ...

By Vertex Pharmaceuticals

An independent investigation, conducted by the Lead-acid Battery Sub-Commission of the China Electric Equipment Industry Association, has indicated that Johnson Controls could not be the cause of the elevated blood-lead levels that have been found in some children in the Kangqiao area, Pudong, Shanghai. "We believe this is a comprehensive investigation based on facts," said Alex Molinaroli, ...

By Johnson Controls, Inc.